Cargando…
Economic Analysis of Thrombo inCode, a Clinical–Genetic Function for Assessing the Risk of Venous Thromboembolism
BACKGROUND: Patients with venous thromboembolism (VTE) commonly have an underlying genetic predisposition. However, genetic tests nowadays in use have very low sensitivity for identifying subjects at risk of VTE. Thrombo inCode(®) is a new genetic tool that has demonstrated very good sensitivity, th...
Autores principales: | Rubio-Terrés, C., Soria, J. M., Morange, P. E., Souto, J. C., Suchon, P., Mateo, J., Saut, N., Rubio-Rodríguez, D., Sala, J., Gracia, A., Pich, S., Salas, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376955/ https://www.ncbi.nlm.nih.gov/pubmed/25652150 http://dx.doi.org/10.1007/s40258-015-0153-x |
Ejemplares similares
-
Economic Evaluation of Cardio inCode(®), a Clinical-Genetic Function for Coronary Heart Disease Risk Assessment
por: Ramírez de Arellano, A., et al.
Publicado: (2013) -
Multilocus Genetic Risk Scores for Venous Thromboembolism Risk Assessment
por: Soria, José Manuel, et al.
Publicado: (2014) -
Common Risk Factors Add to Inherited Thrombophilia to Predict Venous Thromboembolism Risk in Families
por: Suchon, Pierre, et al.
Publicado: (2019) -
Protein S Heerlen mutation heterozygosity is associated with venous thrombosis risk
por: Suchon, P., et al.
Publicado: (2017) -
The use of anticoagulants for venous thrombo-embolism
Publicado: (2010)